Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Two new COVID-19 antigen tests added to the Laboratory Test Nomenclature in Finland in July 2021

In late July 2021, two new COVID-19 antigen tests were added to the Laboratory Test Nomenclature (Laboratoriotutkimusnimikkeistö) in Finland. The newly introduced tests include:

  • 7903 mariPOC Quick Flu+, ArcDia International Ltd
  • 7906 mariPOC Respi+, ArcDia International Ltd

The Laboratory Tests Nomenclature is maintained by the Association of Local and Regional Authorities. Nomenclature codes are used for the unification of coding of laboratory procedures in Finland. The Laboratory Tests Nomenclature is also used to code the tests in private settings with coverage from the national public payor (KELA).

The full details in Finish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.